Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02016339
Other study ID # CPAPCOMPL-01
Secondary ID
Status Completed
Phase N/A
First received November 27, 2013
Last updated December 20, 2013
Start date June 2007
Est. completion date October 2013

Study information

Verified date December 2013
Source University of Crete
Contact n/a
Is FDA regulated No
Health authority Greece: Ethics Committee
Study type Interventional

Clinical Trial Summary

The purpose of this study was to compare the effects on sleepiness, quality of life, depression, hospitalization and deaths rate, of intensive vs standard interventions, on CPAP adherence, 2 years after CPAP initiation.


Description:

There is limited data concerning long-term randomized clinical trials proving the long-term efficacy of intensive use, follow programs on improving CPAP use. Therefore the investigators aimed to compare the effects on sleepiness, quality of life, depression, hospitalization and deaths rate, of intensive vs standard interventions, on CPAP adherence, 2 years after CPAP initiation.


Recruitment information / eligibility

Status Completed
Enrollment 2836
Est. completion date October 2013
Est. primary completion date June 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- newly diagnosed obstructive sleep apnea syndrome by polysomnography according to standard criteria,

- with moderate to severe sleep apnea,

- no history of previously CPAP therapy and

- with an above-elementary school education.

Exclusion Criteria:

- refusal to participate,

- refusal to CPAP therapy,

- previous CPAP treatment,

- central sleep apnoea syndrome,

- Cheyne-stokes breathing pattern,

- obesity hypoventilation syndrome,

- restrictive ventilator syndromes,

- congestive heart failure,

- history of life-threatening arrhythmias,

- cardiomyopathy,

- long term oxygen therapy,

- family or personal history of mental illness,

- with drug or alcohol abuse,

- severe cognitive impairment,

- concurrent oncologic diseases and

- history of narcolepsy.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
Standard care
24-h consultation telephone line to the sleep nurses to answer questions regarding CPAP usage. Patients were reviewed at 1 month and at 3 month intervals during the first year and every 6 months thereafter in the CPAP clinic by the nurse. Additional visits or phone calls by sleep specialist if doubts about a patient's compliance or willingness to continue with the therapy.
Intensive care
Standard group care plus: Involvement of the patient's partner or family necessary. Extra education on sleep apnea and CPAP by sleep specialists via a 15-min videotape. 10- to 15-min lecture from the sleep clinic's nurses after CPAP titration study. Phone calls by nurses at 2 and 7 days. Early review of patients by sleep specialists at 15 and 30 days. Home visits by sleep nurses, if there doubts about a patients adherence

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Crete

Outcome

Type Measure Description Time frame Safety issue
Other Effect of intensive intervention on hospitalization rate. 24 months No
Other Effect of intensive intervention on withdrawal of CPAP 24 months No
Primary Effect of intensive intervention on CPAP adherence 24 months No
Secondary Effect of intensive intervention on sleepiness. 24 months No
Secondary Effect of intensive intervention on mood. 24 months No
Secondary Effect of intensive intervention on quality of life 24 months No
See also
  Status Clinical Trial Phase
Completed NCT05582070 - Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction N/A
Recruiting NCT03919955 - A Novel Pharmacological Therapy for Obstructive Sleep Apnea Phase 2
Completed NCT03927547 - Sleep Disordered Breathing and Cardiopulmonary Disease in Peruvian Highlanders N/A
Recruiting NCT04007380 - Psychosocial, Cognitive, and Behavioral Consequences of Sleep-disordered Breathing After SCI N/A
Completed NCT02188498 - Electrocardiography Data Analysis in Sleep Disorders
Completed NCT01503164 - Effects of Continuous Positive Airway Pressure (CPAP) on Glucose Metabolism N/A
Recruiting NCT00747890 - Surgical Treatment of Mild Obstructive Sleep Apnea N/A
Active, not recruiting NCT00738179 - Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea to Prevent Cardiovascular Disease Phase 3
Completed NCT00841906 - Alice PDx User/Validation Extended Trial N/A
Completed NCT00202501 - Usefulness of Nasal Continuous Positive Airway Pressure (CPAP) Treatment in Patients With a First Ever Stroke and Sleep Apnea Syndrome N/A
Completed NCT00047463 - Effects of Treating Obstructive Sleep Apnea in Epilepsy Phase 2
Not yet recruiting NCT06029881 - Portable System for Non-intrusive Monitoring of Sleep
Recruiting NCT06093347 - Central Apnoea Monitor Study
Terminated NCT05445869 - Severe OSA Study (SOS) N/A
Withdrawn NCT04096261 - The Importance of Sleep Quality and the Blood-brain Barrier in Cognitive Disorders and Alzheimer's Disease
Recruiting NCT04575740 - Phenotyping Mechanistic Pathways for Adverse Health Outcomes in Sleep Apnea N/A
Completed NCT04676191 - Validation of a Contactless Vital Signs Measurement Sensor N/A
Recruiting NCT06015620 - Comorbidities Resolution After MGB Surgery and Change in Body Composition
Completed NCT06051097 - Metabolic Syndrome and Obstructive Sleep Apnea
Completed NCT05687097 - Untreated Sleep Apnea as an Aggravating Factor for Other Secondary Medical Conditions After Spinal Cord Injury